Valeant Buys U.S. Eye Surgery Device Maker Synergetics

Source: SF Gate

Sep 03, 2015

Canadian acquisition giant Valeant Pharmaceuticals announced it will buy eye surgery product maker Synergetics USA for as much as $192 million.

Missouri-based Synergetics manufactures devices primarily for use in vitreoretinal surgery and neurosurgical applications. This acquisition will strengthen Bausch+Lomb business, which Valeant bought for $8.7 billion in 2013.

Earlier this week, Valeant announced that it will collaborate with AstraZeneca on psoriasis treatment brodalumab, after Amgen dropped out of the deal in May.

Read the SF Gate release

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments